Professional article
French

Place de l'immunothérapie dans l'asthme allergique

Published inRevue médicale suisse, vol. 14, no. 601, p. 731-734
Publication date2018
Abstract

Desensitization for pneumallergens is used in daily practice for the treatment of allergic rhinitis and allergic asthma. However, specific immunotherapy has long been debated in the medical literature as a treatment for allergic asthma until the latest international recommendations for the management of asthma (GINA) reveal specific immunotherapy as a treatment in sensitized patients, poorly controlled by inhaled corticosteroids (FEV 1 > 70%). In this article you will find a current overview of the medical literature on the usefulness of specific desensitization to reduce asthma symptoms and symptomatic treatments, prevent the onset of asthma in patients with allergic rhinitis as well as prevent new sensitizations.

Citation (ISO format)
MARCHAL, Ophélie, ALLALI, Danièle. Place de l’immunothérapie dans l’asthme allergique. In: Revue médicale suisse, 2018, vol. 14, n° 601, p. 731–734.
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN1660-9379
287views
1downloads

Technical informations

Creation07/11/2019 10:24:00
First validation07/11/2019 10:24:00
Update time15/03/2023 18:26:03
Status update15/03/2023 18:26:02
Last indexation31/10/2024 17:00:18
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack